Dana-Farber/Boston Children’s is an integrated pediatric hematology and* oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. We offer, in one specialized program, the full spectrum of services that are needed for diagnosis, treatment, and ongoing care of even the rarest and hard-to-treat conditions.
Hematologists and oncologists, who are both clinicians and active researchers, form the core of our lymphoma treatment team. They are supported by pediatric radiation oncologists, surgeons, oncology nurses, and other medical specialists.
We are a founding member of a small national consortium of leading medical centers investigating treatments for childhood lymphoma, including innovative drug combinations that deliver results with fewer long-term complications. Our physicians also are involved in clinical trials for newly diagnosed patients and investigational drug therapies at the time of relapse.
Learn more about our Lymphoma Program on the Dana-Farber Cancer Institute website.
